Cargando…

Atypical “accelerated” chronic lymphocytic leukemia with abnormal lymphocyte chromatin clumping, bone involvement, and exceptional response to Imbruvica

BACKGROUND: The “accelerated” chronic lymphocytic leukemia (aCLL) is a relatively rare form of CLL progression. The expanded proliferation centers in aCLL have been associated with adverse prognostic features and propensity to more aggressive behavior with shorter survival. CASE: An atypical case of...

Descripción completa

Detalles Bibliográficos
Autor principal: Yavorkovsky, Leonid L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458487/
https://www.ncbi.nlm.nih.gov/pubmed/35075812
http://dx.doi.org/10.1002/cnr2.1601
_version_ 1784786306691235840
author Yavorkovsky, Leonid L.
author_facet Yavorkovsky, Leonid L.
author_sort Yavorkovsky, Leonid L.
collection PubMed
description BACKGROUND: The “accelerated” chronic lymphocytic leukemia (aCLL) is a relatively rare form of CLL progression. The expanded proliferation centers in aCLL have been associated with adverse prognostic features and propensity to more aggressive behavior with shorter survival. CASE: An atypical case of aCLL with distinct features is described. A 66‐year‐old female presented with a marrow replacing process associated with multiple osseous metastases and trivial lymphadenopathy. Bone biopsy revealed an unspecified low‐grade B cell lymphoproliferative disorder that demonstrated a suboptimal response to standard chemotherapy. Subsequent lymph node biopsy demonstrated findings consisted with aCLL. The distinguishing features of the case were, in addition to bone involvement, the lagging peripheral lymphocytosis and a striking pattern of the chromatin clumping with a prominent “shattered” appearance reminiscent of Pelger‐Huet‐like dysplastic anomaly. A targeted next‐generation sequencing (NGS) assay detected pathogenic mutations in TP53 and SF3B1. In contrast to chemotherapy, the case demonstrated an excellent response to imbruvica. CONCLUSION: The noted peculiarities could potentially distinguish this case as a novel, rare variant of aCLL.
format Online
Article
Text
id pubmed-9458487
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-94584872022-09-12 Atypical “accelerated” chronic lymphocytic leukemia with abnormal lymphocyte chromatin clumping, bone involvement, and exceptional response to Imbruvica Yavorkovsky, Leonid L. Cancer Rep (Hoboken) Case Reports BACKGROUND: The “accelerated” chronic lymphocytic leukemia (aCLL) is a relatively rare form of CLL progression. The expanded proliferation centers in aCLL have been associated with adverse prognostic features and propensity to more aggressive behavior with shorter survival. CASE: An atypical case of aCLL with distinct features is described. A 66‐year‐old female presented with a marrow replacing process associated with multiple osseous metastases and trivial lymphadenopathy. Bone biopsy revealed an unspecified low‐grade B cell lymphoproliferative disorder that demonstrated a suboptimal response to standard chemotherapy. Subsequent lymph node biopsy demonstrated findings consisted with aCLL. The distinguishing features of the case were, in addition to bone involvement, the lagging peripheral lymphocytosis and a striking pattern of the chromatin clumping with a prominent “shattered” appearance reminiscent of Pelger‐Huet‐like dysplastic anomaly. A targeted next‐generation sequencing (NGS) assay detected pathogenic mutations in TP53 and SF3B1. In contrast to chemotherapy, the case demonstrated an excellent response to imbruvica. CONCLUSION: The noted peculiarities could potentially distinguish this case as a novel, rare variant of aCLL. John Wiley and Sons Inc. 2022-01-24 /pmc/articles/PMC9458487/ /pubmed/35075812 http://dx.doi.org/10.1002/cnr2.1601 Text en © 2022 The Author. Cancer Reports published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Yavorkovsky, Leonid L.
Atypical “accelerated” chronic lymphocytic leukemia with abnormal lymphocyte chromatin clumping, bone involvement, and exceptional response to Imbruvica
title Atypical “accelerated” chronic lymphocytic leukemia with abnormal lymphocyte chromatin clumping, bone involvement, and exceptional response to Imbruvica
title_full Atypical “accelerated” chronic lymphocytic leukemia with abnormal lymphocyte chromatin clumping, bone involvement, and exceptional response to Imbruvica
title_fullStr Atypical “accelerated” chronic lymphocytic leukemia with abnormal lymphocyte chromatin clumping, bone involvement, and exceptional response to Imbruvica
title_full_unstemmed Atypical “accelerated” chronic lymphocytic leukemia with abnormal lymphocyte chromatin clumping, bone involvement, and exceptional response to Imbruvica
title_short Atypical “accelerated” chronic lymphocytic leukemia with abnormal lymphocyte chromatin clumping, bone involvement, and exceptional response to Imbruvica
title_sort atypical “accelerated” chronic lymphocytic leukemia with abnormal lymphocyte chromatin clumping, bone involvement, and exceptional response to imbruvica
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458487/
https://www.ncbi.nlm.nih.gov/pubmed/35075812
http://dx.doi.org/10.1002/cnr2.1601
work_keys_str_mv AT yavorkovskyleonidl atypicalacceleratedchroniclymphocyticleukemiawithabnormallymphocytechromatinclumpingboneinvolvementandexceptionalresponsetoimbruvica